Search

everythinglearnresearchcommunity

for

Search:↓

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Prolactin levels are higher in women with hirsutism but don't relate to its severity.

Early menarche may indicate higher risk of severe hirsutism in PCOS patients.

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.

Efficient PCOS screening is crucial for early detection, with lifestyle factors like fruit intake potentially aiding prevention.

Hirsutism can occur in women with PCOS even if their androgen levels are normal, making diagnosis challenging.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Higher anxiety levels are linked to sexual dysfunction in women with PCOS.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Intense Pulsed Light is an effective and safe hair removal method for people with excessive hair growth.

Lifestyle changes can significantly improve hair loss in overweight women with PCOS.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.